Daniel W Cramer1, William R Welch, Ross S Berkowitz, John J Godleski. 1. Department of Obstetrics, Gynecology, and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. dcramer@partners.org
Abstract
BACKGROUND: Although epidemiologic studies suggest talc use may increase ovarian cancer risk, there is no proof that talc used externally reaches the pelvis. CASE: A 68-year-old woman with stage III ovarian papillary serous carcinoma revealed she had used talc daily for 30 years to powder her genital area. Examination of her pelvic lymph nodes under polarized light microscopy showed diffuse areas of birefringence compatible with talc, confirmed by scanning electron microscopy and X-ray spectroscopy. CONCLUSION: This description of talc in pelvic lymph nodes of a woman with ovarian cancer and decades of exposure to talc may prompt new studies and offer new insights into the biologic basis for the consistent, but debated, association between talc use and ovarian cancer.
BACKGROUND: Although epidemiologic studies suggest talc use may increase ovarian cancer risk, there is no proof that talc used externally reaches the pelvis. CASE: A 68-year-old woman with stage III ovarian papillary serous carcinoma revealed she had used talc daily for 30 years to powder her genital area. Examination of her pelvic lymph nodes under polarized light microscopy showed diffuse areas of birefringence compatible with talc, confirmed by scanning electron microscopy and X-ray spectroscopy. CONCLUSION: This description of talc in pelvic lymph nodes of a woman with ovarian cancer and decades of exposure to talc may prompt new studies and offer new insights into the biologic basis for the consistent, but debated, association between talc use and ovarian cancer.
Authors: Simone P Pinheiro; Susan E Hankinson; Shelley S Tworoger; Bernard A Rosner; John R McKolanis; Olivera J Finn; Daniel W Cramer Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-05-25 Impact factor: 4.254
Authors: Stalo Karageorgi; Margaret A Gates; Susan E Hankinson; Immaculata De Vivo Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-04-20 Impact factor: 4.254
Authors: Sandra A McDonald; Yuwei Fan; William R Welch; Daniel W Cramer; John J Godleski Journal: Am J Clin Pathol Date: 2019-10-07 Impact factor: 2.493
Authors: Margaret A Gates; Shelley S Tworoger; Kathryn L Terry; Linda Titus-Ernstoff; Bernard Rosner; Immaculata De Vivo; Daniel W Cramer; Susan E Hankinson Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-09 Impact factor: 4.254
Authors: William H Parker; Michael S Broder; Eunice Chang; Diane Feskanich; Cindy Farquhar; Zhimae Liu; Donna Shoupe; Jonathan S Berek; Susan Hankinson; JoAnn E Manson Journal: Obstet Gynecol Date: 2009-05 Impact factor: 7.661
Authors: T Emi; L M Rivera; V C Tripathi; N Yano; A Ragavendran; J Wallace; Alexey V Fedulov Journal: Epigenetics Date: 2020-10-30 Impact factor: 4.528
Authors: Angelo Mandarino; David J Gregory; Connor C McGuire; Brian W Leblanc; Hadley Witt; Loreilys Mejias Rivera; John J Godleski; Alexey V Fedulov Journal: Environ Res Date: 2019-08-22 Impact factor: 6.498
Authors: Yin P Hung; Fei Dong; Jaclyn C Watkins; Valentina Nardi; Raphael Bueno; Paola Dal Cin; John J Godleski; Christopher P Crum; Lucian R Chirieac Journal: JAMA Oncol Date: 2018-02-01 Impact factor: 31.777